Floatz logo

carbidopa

Opioid Use

Northwestern UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

32 Active assets in the Opioid Use cohort.

Asset / SponsorPhaseRating
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Wake Forest University Health Sciences
Phase 4BBB
FENTANYL
University of Crete
Phase 4BB
Bxcl501
Kaohsiung Veterans General Hospital.
Phase 4BB
Oxycodone
Wake Forest University Health Sciences
Phase 4BB
LIDOCAINE
Tanta University
Phase 4BB

View all 38 →

Same molecule, other indications

carbidopa is also rated in:

drug-induced dyskinesiaDormant
BBB
Indicative ·
75 / 100
View asset →
Parkinson diseaseDormant
BBB
Indicative ·
75 / 100
View asset →
impulse control disorderDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →